FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

18297311000001103: Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jan 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62652101000001110 Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62652201000001115 Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Is a Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Naloxone true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Oromucosal AND/OR gingival dosage form false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Naloxone hydrochloride false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Is a Suboxone true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Naloxone true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP True Suboxone 2mg/500microgram sublingual tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start